https://www.cancerresearch.org/events/webinars/cancer-immunotherapy-2021-research-look-ahead?utm_source=luminate&utm_medium=email&utm_campaign=webinars&utm_content=jan-2021
A very good webinar from the Cancer Research Institute on the future of immune therapies for cancer.
If you don’t have time to watch it start around the 33 minute mark where he talks about the change taking
place for FDA approvals and that you can have approvals come much earlier than phase 3. Something
that should apply to IMU!
Ann: Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial, page-39
-
- There are more pages in this discussion • 264 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |